 The Food and Drug Administration has approved Eli Lilly and company's new drug to treat Alzheimer's disease. The therapy is called Kinsula and costs roughly $32,000 for the first year of treatment. Shares of Eli Lilly taped 8 tenths percent. Today, Tesla posted better than it predicted quarterly results. Sales were down, but not as much as expected. This being capitalism, Tesla accelerated 2 and 2 tenths of 1 percent. Today, bonds rose. Yield on the 10-year T-note down 4.43 percent. You're listening to Marketplace.